1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Aurora Spine Corporation

Aurora Spine Corporation

ASG.V
Aurora Spine CorporationCA flagToronto Stock Exchange Ventures
0.24
CAD
- -
- -
18.74MMarket Cap

Total Valuation

Aurora Spine Corporation carries a market capitalization of 18.74M, placing it among publicly traded companies globally. Its enterprise value stands at 17.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap18.74M
Enterprise Value17.97M

Share Statistics

Aurora Spine Corporation currently has 78.09M shares outstanding.

Shares Outstanding78.09M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.83, and the price-to-book ratio stands at 62.44.

PE RatioN/A
PS Ratio0.83
PB Ratio62.44
P/TBV Ratio4.85
P/FCF Ratio10.49
P/OCF Ratio16.71

Enterprise Valuation

On an enterprise value basis, Aurora Spine Corporation trades at an EV/EBITDA multiple of 24.26 and an EV/FCF ratio of 11.03.

EV / Sales0.98
EV / EBITDA24.26
EV / EBITN/A
EV / FCF11.03

Financial Position

Aurora Spine Corporation maintains a current ratio of 2.33, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 92.84, indicating elevated leverage, while an interest coverage ratio of 4.40 demonstrates adequate ability to service its debt obligations.

Current Ratio2.33
Quick Ratio1.26
Debt / Equity92.84
Debt / EBITDA4.78
Interest Coverage4.40

Financial Efficiency

Return on Equity (ROE)-129.95
Return on Assets (ROA)-6.81
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.09

Stock Price Statistics

Aurora Spine Corporation's stock has declined approximately -25% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.28.

Beta (5Y)N/A
52-Week Price Change-25%
50-Day Moving Average0.26
200-Day Moving Average0.28
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Aurora Spine Corporation generated 18.37M in revenue and converted that into -731,120.00 in net income, yielding earnings per share of -0.01. EBITDA reached 740,765.00, while operating income came in at -329,984.00.

Revenue18.37M
Gross Profit11.20M
Operating Income-329,984.00
Pretax Income-731,120.00
Net Income-731,120.00
EBITDA740,765.00
EBIT-329,984.00
Earnings Per Share (EPS)-0.01

Balance Sheet

Aurora Spine Corporation holds 896,713.00 in cash and equivalents against 3.54M in total debt, resulting in a net debt position of 1.95M. Total book value stands at 245,540.00, with working capital of 4.45M providing operational flexibility.

Cash & Cash Equivalents896,713.00
Total Debt3.54M
Net Debt1.95M
Equity (Book Value)245,540.00
Book Value Per Share0.00
Working Capital4.45M

Cash Flow

Aurora Spine Corporation produced 917,366.00 in operating cash flow over the past twelve months. After subtracting -543,612.00 in capital expenditures, free cash flow totaled 373,754.00 - equivalent to 0.00 per share.

Operating Cash Flow917,366.00
Capital Expenditures-543,612.00
Free Cash Flow373,754.00
FCF Per Share0.00

Margins

Aurora Spine Corporation operates with a gross margin of 60.97, reflecting its pricing power and cost economics. The operating margin of -1.80 and net profit margin of -3.98 provide insight into operational efficiency.

Gross Margin60.97
Operating Margin-1.80
Pretax Margin-3.98
Profit Margin-3.98
EBITDA Margin4.03

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield1.97
FCF Yield9.53

Scores

Aurora Spine Corporation posts an Altman Z-Score of -0.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.23